78 experts were identified. There were 24 from Canada, 31 from the United States, 5 from Mexico and 18 from the United Kingdom. Out of 78, 74% relied to the questionnaire. Three-quarters of those who replied were male physicians and their average age was 51 years old. The typical doctor who replied followed at least 75 people with SLE each and had four or five of their patients become pregnant every year. Survey results found:

• 42% said they often or always continued antimalarials drugs during pregnancy,
• 27% said sometimes,
• and 32% said never or rarely.
• The more pregnant persons with SLE that the individual physician cared for, the more likely they were to continue hydroxychloroquine in pregnancy. Also, the more recently the individual had graduated from medical school, the more likely they were to continue the hydroxychloroquine. Those physicians who tended to continue hydroxychloroquine during pregnancy were also significantly more likely to start hydroxychloroquine during pregnancy for a flare-up in women who were not taking it. None of the physicians reported having ever seen any problems to a baby with antimalarial use. When the issue of breast feeding was raised, two-thirds of the physicians advised the patient to continue antimalarials throughout breast feeding and about a quarter suggested continuing antimalarials, but bottle feeding the baby. Only 13% stopped antimalarials. It is known that very little hydroxychloroquine gets into breast milk.